Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-22 Sale |
2022-02-23 5:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $7.85 | $31,400 | 181,077 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 6:59 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
281,170 | $7.1885 | $2,021,188 | 675,032 (Indirect Direct) |
View |
| 2022-02-04 Sale |
2022-02-07 5:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas |
4,000 | $7.97 | $31,880 | 185,077 (Direct) |
View |
| 2022-02-03 Sale |
2022-02-07 5:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
136,164 | $7.7521 | $1,055,558 | 956,202 (Indirect Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 5:00 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
8,000 | $10.15 | $81,161 | 1,245,366 (Indirect Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 5:09 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
88,055 | $10.63 | $936,412 | 1,092,366 (Indirect Direct) |
View |
| 2022-01-24 Sale |
2022-01-25 5:01 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $9.84 | $39,360 | 189,077 (Direct) |
View |
| 2022-01-20 Sale |
2022-01-24 5:39 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
183,085 | $11.1 | $2,033,105 | 1,180,421 (Indirect Direct) |
View |
| 2022-01-18 Sale |
2022-01-20 5:13 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
77,814 | $10.96 | $852,990 | 1,524,506 (Indirect Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 5:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $17.12 | $68,480 | 193,077 (Direct) |
View |
| 2021-12-22 Sale |
2021-12-23 4:55 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $16.36 | $65,440 | 197,077 (Direct) |
View |
| 2021-12-06 Sale |
2021-12-08 5:18 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
54,000 | $16.69 | $901,074 | 1,433,320 (Indirect Direct) |
View |
| 2021-12-06 Sale |
2021-12-07 5:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $16.35 | $65,400 | 201,077 (Direct) |
View |
| 2021-11-29 Sale |
2021-12-01 5:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
47,607 | $17.11 | $814,483 | 1,487,320 (Indirect Direct) |
View |
| 2021-11-23 Sale |
2021-11-26 5:33 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
50,000 | $17.06 | $852,850 | 1,703,927 (Indirect Direct) |
View |
| 2021-11-22 Sale |
2021-11-23 5:06 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $18.09 | $72,360 | 205,077 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 5:18 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $19.33 | $77,302 | 1,534,927 (Indirect Direct) |
View |
| 2021-11-04 Sale |
2021-11-05 5:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $27.54 | $110,160 | 209,077 (Direct) |
View |
| 2021-10-29 Sale |
2021-11-01 5:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $24.82 | $99,261 | 1,538,927 (Indirect Direct) |
View |
| 2021-10-22 Sale |
2021-10-26 6:04 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $25.94 | $103,760 | 213,077 (Direct) |
View |
| 2021-10-15 Sale |
2021-10-19 5:17 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $27.2 | $108,799 | 1,542,927 (Indirect Direct) |
View |
| 2021-10-04 Sale |
2021-10-05 5:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
4,000 | $28.78 | $115,120 | 217,077 (Direct) |
View |
| 2021-09-30 Sale |
2021-10-04 5:17 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
4,000 | $28.26 | $113,054 | 1,546,927 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-18 Option Award |
2022-05-19 4:16 pm |
N/A 2032-05-18 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 6:22 pm |
N/A 2032-04-26 |
Y-mAbs Therapeutics Inc. | YMAB | Rajah Vignesh SVP & CMO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 6:21 pm |
N/A 2032-04-26 |
Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CTO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 6:20 pm |
N/A 2032-04-26 |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CCO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 6:19 pm |
N/A 2032-04-26 |
Y-mAbs Therapeutics Inc. | YMAB | Lisby Steen SVP & CSO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 6:18 pm |
N/A 2032-04-26 |
Y-mAbs Therapeutics Inc. | YMAB | Wilms Joris SVP & COO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 6:16 pm |
N/A 2032-04-26 |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 5:00 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
8,000 | $0 | 1,245,366 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 5:00 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
8,000 | $2 | 1,245,366 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 5:13 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
8,000 | $0 | 1,524,506 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 5:13 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
8,000 | $2 | 1,524,506 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-23 4:55 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CCO |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-12-14 Gift |
2021-12-16 6:35 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
60,000 | $0 | 1,433,320 (Indirect) |
View |
| 2021-12-14 Option Award |
2021-12-16 6:05 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Rajah Vignesh SVP & CMO |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 6:05 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CTO |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 6:04 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
110,000 | $0 | 110,000 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 6:04 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Lisby Steen SVP & CSO |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 6:02 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Wilms Joris SVP & COO |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 6:01 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Moller-San Pedro Claus Juan Director and CEO |
230,000 | $0 | 230,000 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 6:01 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 5:33 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
50,000 | $0 | 1,703,927 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 5:33 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas See remarks |
50,000 | $2 | 1,703,927 (Direct) |
View |